<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated by the NIST, Thermodynamics Research Center (http://www.trc.nist.gov) -->
<DataReport xmlns="http://www.iupac.org/namespaces/ThermoML"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xsi:schemaLocation="http://www.iupac.org/namespaces/ThermoML http://trc.nist.gov/ThermoML.xsd">
  <Version>
    <nVersionMajor>2</nVersionMajor>
    <nVersionMinor>0</nVersionMinor>
  </Version>
  <Citation>
    <TRCRefID>
      <yrYrPub>2014</yrYrPub>
      <sAuthor1>sha</sAuthor1>
      <sAuthor2>vel</sAuthor2>
      <nAuthorn>0</nAuthorn>
    </TRCRefID>
    <eType>journal</eType>
    <eSourceType>Original</eSourceType>
    <sAuthor>Shayanfar, Ali</sAuthor>
    <sAuthor>Velaga, Sitaram</sAuthor>
    <sAuthor>Jouyban, Abolghasem</sAuthor>
    <sPubName>Fluid Phase Equilib.</sPubName>
    <yrPubYr>2014</yrPubYr>
    <dateCit>2020-09-29</dateCit>
    <sTitle>Solubility of carbamazepine, nicotinamide and carbamazepine-nicotinamide cocrystal in ethanol-water mixtures</sTitle>
    <sAbstract>Soly. is an important physiochem. property of pharmaceutical compds., and cocrystn. is one method used to improve the soly. of drugs.  Carbamazepine is a drug from class II, according to the biopharmaceutical classification system, and it forms a cocrystal with nicotinamide.  Carbamazepine cocrystd. with nicotinamide was synthesized using the solvent evapn. approach, and its characteristics were detd. using differential scanning calorimetry and powder X-ray diffractometry.  The soly. of various solid phases in ethanol + water mixts. was investigated at different temps. using the shake-flask method, and the resulting ppts. were characterized.  The soly. of carbamazepine was increased with the addn. of ethanol up to a mass fraction of 0.8.  Nevertheless, max. soly. of NIC is obsd. in neat solvent (water).  While the soly. of a cocrystal depends on the concn. of the coformer and its stability in the soln.</sAbstract>
    <sDOI>10.1016/j.fluid.2013.11.024</sDOI>
    <sVol>363</sVol>
    <sPage>97-105</sPage>
  </Citation>
  <Compound>
    <RegNum>
      <nOrgNum>1</nOrgNum>
    </RegNum>
    <sStandardInChI>InChI=1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9)</sStandardInChI>
    <sStandardInChIKey>DFPAKSUCGFBDDF-UHFFFAOYSA-N</sStandardInChIKey>
    <sCommonName>3-pyridinecarboxamide</sCommonName>
    <sCommonName>niacinamide</sCommonName>
    <sCommonName>nicotinamide</sCommonName>
    <sCommonName>nicotinic acid amide</sCommonName>
    <sFormulaMolec>C6H6N2O</sFormulaMolec>
    <Sample>
      <nSampleNm>1</nSampleNm>
      <eStatus>notDescribed</eStatus>
    </Sample>
  </Compound>
  <Compound>
    <RegNum>
      <nOrgNum>2</nOrgNum>
    </RegNum>
    <sStandardInChI>InChI=1S/H2O/h1H2</sStandardInChI>
    <sStandardInChIKey>XLYOFNOQVPJJNP-UHFFFAOYSA-N</sStandardInChIKey>
    <sCommonName>water</sCommonName>
    <sFormulaMolec>H2O</sFormulaMolec>
    <Sample>
      <nSampleNm>1</nSampleNm>
      <eStatus>notDescribed</eStatus>
    </Sample>
  </Compound>
  <PureOrMixtureData>
    <nPureOrMixtureDataNumber>1</nPureOrMixtureDataNumber>
    <Component>
      <RegNum>
        <nOrgNum>1</nOrgNum>
      </RegNum>
      <nSampleNm>1</nSampleNm>
    </Component>
    <Component>
      <RegNum>
        <nOrgNum>2</nOrgNum>
      </RegNum>
      <nSampleNm>1</nSampleNm>
    </Component>
    <eExpPurpose>Principal objective of the work</eExpPurpose>
    <sCompiler>VVD</sCompiler>
    <sContributor>TRC</sContributor>
    <dateDateAdded>3/25/2019</dateDateAdded>
    <Property>
      <nPropNumber>1</nPropNumber>
      <Property-MethodID>
        <PropertyGroup>
          <CompositionAtPhaseEquilibrium>
            <ePropName>Amount concentration (molarity), mol/dm3</ePropName>
            <sMethodName>?</sMethodName>
          </CompositionAtPhaseEquilibrium>
        </PropertyGroup>
        <RegNum>
          <nOrgNum>1</nOrgNum>
        </RegNum>
      </Property-MethodID>
      <PropPhaseID>
        <ePropPhase>Liquid</ePropPhase>
      </PropPhaseID>
      <ePresentation>Direct value, X</ePresentation>
      <Solvent>
        <RegNum>
          <nOrgNum>2</nOrgNum>
        </RegNum>
      </Solvent>
    </Property>
    <PhaseID>
      <ePhase>Liquid</ePhase>
    </PhaseID>
    <PhaseID>
      <ePhase>Crystal</ePhase>
      <RegNum>
        <nOrgNum>1</nOrgNum>
      </RegNum>
    </PhaseID>
    <Variable>
      <nVarNumber>1</nVarNumber>
      <VariableID>
        <VariableType>
          <eTemperature>Temperature, K</eTemperature>
        </VariableType>
      </VariableID>
      <VarPhaseID>
        <eVarPhase>Liquid</eVarPhase>
      </VarPhaseID>
    </Variable>
    <Variable>
      <nVarNumber>2</nVarNumber>
      <VariableID>
        <VariableType>
          <ePressure>Pressure, kPa</ePressure>
        </VariableType>
      </VariableID>
      <VarPhaseID>
        <eVarPhase>Liquid</eVarPhase>
      </VarPhaseID>
    </Variable>
    <NumValues>
      <VariableValue>
        <nVarNumber>1</nVarNumber>
        <nVarValue>298.2</nVarValue>
        <nVarDigits>4</nVarDigits>
      </VariableValue>
      <VariableValue>
        <nVarNumber>2</nVarNumber>
        <nVarValue>101</nVarValue>
        <nVarDigits>3</nVarDigits>
      </VariableValue>
      <PropertyValue>
        <nPropNumber>1</nPropNumber>
        <nPropValue>4.06</nPropValue>
        <nPropDigits>3</nPropDigits>
      </PropertyValue>
    </NumValues>
  </PureOrMixtureData>
</DataReport>